March 18, 2018 6:33 PM ET


Company Overview of OcuCure Therapeutics, Inc.

Key Executives for OcuCure Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Sunder H. Malkani No RelationshipsChief Executive Officer and President69
Craig Greven M.D.No RelationshipsChief Medical Officer and Consultant--
Sam English Ph.D.No RelationshipsVice President of Pharmaceutical Services and Consultant--
Patricia B. Williams Ph.D.No RelationshipsChief Scientific Officer and Consultant--

OcuCure Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Stephen M. Martin J.D. 22 RelationshipsHi Tech Partners, LLC70
W. Ben Deibler 3 RelationshipsOcuCure Therapeutics, Inc.--
Richard M. Haugen 8 RelationshipsOcuCure Therapeutics, Inc.--
Paul S. Williams 3 RelationshipsOcuCure Therapeutics, Inc.--
View All Board Members

OcuCure Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
OcuCure Therapeutics, Inc. CEO Compensation
Industry Average


Vivus, Inc. Announces Resignation of Allan L. Shaw from its Audit Committee and Compensation Committee
March 02, 2018 9:06 PM ET
Novartis AG Announces Retirement of Pierre Landolt from the Board of Directors
March 02, 2018 9:00 AM ET
Aurora Cannabis Inc. Appoints Shane Morris as Vice President Product Development and Regulatory Affairs and Kelly Narine as Vice President of Research
March 01, 2018 10:00 PM ET
Bristol-Myers Squibb Company Appoints Jose Baselga as Member of the Board of Directors
March 01, 2018 9:59 PM ET
Tetraphase Pharmaceuticals Promotes Larry Edwards Larry Edwards, Chief Commercial Officer, to Chief Operating Officer
March 01, 2018 9:01 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OcuCure Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at